MedTrace Logo

Comparison of Dietetics Support With and Without Continuous Glucose Monitoring in Individuals With Type 2 Diabetes.

NCT06888687 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 156

Last updated 2025-05-23

No results posted yet for this study

Summary

A parallel, single-blinded, randomised clinical trial conducted remotely across Australia from the Mary MacKillop Institute for Health Research (MMIHR, Australian Catholic University) for individuals with type 2 diabetes, by researchers from Australian Catholic University, University of Adelaide, University of Queensland, University of Wollongong, Monash University, Monash Partners, Deakin University, La Trobe University and Melbourne University.

Conditions

  • Type 2 Diabetes Mellitus (T2DM)
  • Continuous Glucose Measurement
  • Dietary Modification

Interventions

BEHAVIORAL

Dietetic support

Dietary advice will be provided by Accredited Practicing Dietitians (APDs) in line with evidence-based guidelines, specifically the T2DM best-practice guidelines plus Australian Dietary Guidelines (i.e. Australian Guide to Healthy Eating) to improve diet quality, and strategies to promote adherence.

DEVICE

Continuous glucose monitoring

Abbott FreeStyle Libre 2+ CGM sensors will be used to provide feedback on interstitial glucose concentrations over 15 day periods per sensor.

Sponsors & Collaborators

  • Abbott Diabetes Care

    collaborator INDUSTRY

  • University of Adelaide

    collaborator OTHER

  • The University of Queensland

    collaborator OTHER

  • Monash University

    collaborator OTHER

  • University of Melbourne

    collaborator OTHER

  • Deakin University

    collaborator OTHER

  • Australian Catholic University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-05-12
Primary Completion
2026-11-28
Completion
2026-11-28

Countries

  • Australia

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06888687 on ClinicalTrials.gov